Cutaneous Drug Reaction Due to Bortezomib Characterized by Erythematous Reticular Plaques in a Patient With Multiple Myeloma. Dermatol Pract Concept [Internet]. 2024 Oct. 30 [cited 2024 Dec. 6];14(4):e2024243. Available from: https://dpcj.org/index.php/dpc/article/view/4454